JMF
GOSS icon

Johnson Midwest Financial’s Gossamer Bio GOSS Stock Holding History

Johnson Midwest Financial’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-260
Closed -$3K – 311
2021
Q3 		$3K Hold
260
– – ﹤0.01% 249
2021
Q2 		$2K Hold
260
– – ﹤0.01% 255
2021
Q1 		$2K Buy
+260
New +$2.62K ﹤0.01% 234

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Johnson Midwest Financial's GOSS Position: Q4 2021 in Review

Johnson Midwest Financial sold out of Gossamer Bio (GOSS) in Q4 2021, closing a stake of 260 shares — an estimated $3K sold.

Johnson Midwest Financial first reported a position in GOSS in Q1 2021 and held it in 3 quarters. The position peaked at $3K in Q3 2021. 133 funds tracked by Wall St. Rank hold GOSS as of Q4 2021.

  • Johnson Midwest Financial reported no remaining Gossamer Bio position as of Q4 2021 after selling out during the quarter.
  • Johnson Midwest Financial sold 260 Gossamer Bio shares in Q4 2021, an estimated $3K.
  • Johnson Midwest Financial first reported a position in Gossamer Bio in Q1 2021 and held it in 3 quarters.
  • Johnson Midwest Financial's Gossamer Bio position peaked at $3K in Q3 2021.
  • 133 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2021.

Based on Johnson Midwest Financial's 13F filing for Q4 2021, filed 26 Jan 2022.